Brucella melitensis strain Rev.1 is the most effective vaccine against brucellosis in sheep and goats. In Iran, mass vaccination is carried out all over the country in which adult animals are immunized by subcutaneous injection of reduced doses of the vaccine. However, due to antibody responses elicited by vaccination, concomitant implementation of test-andslaughter is impossible. To overcome the problem, vaccination through conjunctival route is recommended. In this study, serological responses of six pregnant Iranian fat-tailed ewes to conjunctival vaccination with standard doses of the vaccine were evaluated using modified Rose Bengal test, serum agglutination test and indirect ELISA. Besides, vaccine strain excretion in milk and vaginal discharges was also examined by microbiological culture of milk and vaginal swab samples taken one day post-parturition. Animals were vaccinated during the second half of gestation. As the results, antibody titers of five (83.3%) ewes decreased to the levels not detectable by the tests within three months after vaccination. No vaccine-induced abortions occurred and vaccinated ewes delivered healthy lambs 50.33±15.56 (mean ± standard deviation) days post-vaccination. Vaccine strain was not isolated from milk and vaginal swab samples. Generally, our study shows full doses of B. melitensis strain Rev.1 can be used conjunctively to vaccinate pregnant Iranian sheep during late pregnancy without abortifacient effects, prolonged antibody responses and vaccine strain excretion in milk and vaginal discharges. Nevertheless, further studies are required to determine safety and immunogenicity of the vaccine in field conditions.
Introduction
Brucellosis in sheep and goats is an important zoonotic disease caused mainly by Brucella melitensis. 1, 2 Vaccination of the host animals with B. melitensis strain Rev.1 is used worldwide for disease control which has been proved to be the most effective vaccine. 3, 4 It is recommended to immunize replacement animals from 3 to 6 months of age with standard doses of vaccine containing at least 10 9 live cells. 5 However, there is evidence that effective control of the disease in countries with high prevalence requires immunization of all susceptible young and adult animals in a mass vaccination campaign which is considered as the most practical measure. [6] [7] [8] One problem with vaccination of adult animals is antibody responses induced by the vaccine which may last for a long time and cause sero-positivity of vaccinated animals in routine serological tests interfering with detection of infected ones. 4, 9, 10 This makes simultaneous implementation of vaccination and testand-slaughter impossible since vaccinated animals are falsely diagnosed as infected. 4 Moreover, vaccine-induced abortion and vaccine strain excretion in milk and vaginal discharges may occur. 5, 10 Vaccination of flocks through conjunctival route is known as one way to solve these problems. 6, 10, 11 Small ruminant brucellosis is an enzootic disease in Iran causing abortion in different parts of the country. 12 Mass vaccination has been the main control measure since 2003 in which adult animals are vaccinated subcutaneously using reduced doses of the vaccine. 12 Nevertheless, there are field reports showing long-lasting sero-positivity of vaccinated adult sheep and goats and abortions in pregnant animals attributed to the vaccination. Therefore, this study was done to evaluate serological responses of pregnant fat-tailed ewes to ocular vaccination with standard doses of B. melitensis strain Rev.1 as well as its safety in terms of abortion induction and vaccine strain excretion in milk and vaginal secretions.
Materials and Methods

Animals and vaccination
Eleven pregnant Iranian fat-tailed ewes were randomly selected from a known brucellosis-free flock. Selected animals were negative in modified Rose Bengal test (mRBT), serum agglutination test (SAT) and indirect ELISA (iELISA) carried out twice with a month's interval. Six ewes were vaccinated during third to fifth month of pregnancy with conjunctival B. melitensis strain Rev.1 vaccine containing 10 9 colony forming units (CFU) per dose. Other ewes were used as controls in which normal saline was used instead of vaccine at the same time. The vaccine used in the study was produced in Razi Vaccine and Serum
Research Institute according to standard procedures. 5, 13 The original seed for vaccine production was obtained from Animal Health and Veterinary Laboratories Agency (AHVLA), Weybridge, UK. Vaccinated and control animals were kept separately in the same conditions.
Serological evaluation
Animals were bled every 2 weeks for three months after immunization to evaluate serological responses to vaccination. Serum samples were examined using mRBT, SAT and iELISA. RBT and SAT antigens were produced in Razi Vaccine and Serum Research Institute based on standard methods, 5,13 as described previously. 14 For mRBT, one drop of the antigen was mixed with three drops of the serum sample. 15 Indirect ELISA was performed using PrioCHECK ® Brucella Ab (Prionics AG, Schlieren, Switzerland) according to the manufacturer's instructions.
Bacteriological examination
To determine vaccine strain excretion in milk and vaginal discharges, milk and vaginal swab samples were taken within 24 hours after abortion or parturition. Milk samples were first centrifuged at 6000-7000 rpm for 15 minutes and then supernatant cream and precipitated pellet were cultured. 13 Swab samples were cultured directly on solid media. Brucella agar medium (BD, USA) was used for vaccine strain isolation which was supplemented with Brucella selective antibiotics (Oxoid, Basingstoke, UK) and 5% (v/v) horse serum following manufacturer's instructions. For each sample, at least 3 plates were inoculated.
Results
Serological responses after vaccination
While control ewes remained negative during the study, vaccinated animals showed antibody responses from the second week after immunization. Percents of positive vaccinated ewes in mRBT and iELISA at two-week intervals over the study period are presented in Figure 1 . Two weeks post-vaccination, all animals were positive in mRBT but none of them in iELISA. Five ewes (83.3%) showed positive results in iELISA after four weeks. The mRBT and iELISA results of each ewe were similar from fourth week on. After 12 weeks, only one vaccinated ewe (16.7%) remained positive detected by the two tests.
Evaluation of antibody titers using SAT demonstrated a falling trend over time ( Figure  2 ). All animals showed increased antibody titers after two weeks which declined gradually afterwards in a way that 5 ewes (83.3%) had no SAT titers twelve weeks after vaccine inoculation. The only ewe, which had antibody titers detectable by SAT, was also reactive in mRBT and iELISA.
Vaccine safety
No abortion occurred following vaccination and all vaccinated animals had normal delivery with healthy lambs 50.33±15.56 (mean±SD) days after vaccine inoculation. B. melitensis strain Rev.1 was not isolated by microbiological methods from milk and vaginal discharges of vaccinated sheep within 24 hours postpartum.
Discussion and Conclusions
In Iran, brucellosis in small ruminants is an important enzootic disease which is a public health burden. Nomadic raising of sheep and goats, traditional production practices, illegal animal imports and uncontrolled movements of flocks within the country contribute to the difficulties in disease control. In these conditions, control of the disease has been mainly based on mass vaccination of young and adult animals using subcutaneous administration of full and reduced doses of B. melitensis strain Rev.1, respectively. 12 However, the disease still remains prevalent in different parts of the country diagnosed as a significant cause of abortion in sheep and goats. 12 Although we previously demonstrated that reduced doses containing less than or equal to 10 6 bacteria can be safely used to immunize pregnant ewes with short-lasting serological responses, 14 field reports show persistence antibody responses and abortions caused by vaccination. It is known that the innocuousness of the vaccine in adult and pregnant animals depends on vaccine dose, time of vaccination during gestation and administration route. 8, 16 Hence, these observations may be partly due to the fact that according to a standard approved by National Brucellosis Expert Committee, the reduced dose of vaccine used for adult animals immunization can contain up to 4×10 6 colony forming units (CFU) per dose. In addition, subcutaneous use of vaccine and extended lambing season in Iran, which results in presence of pregnant animals throughout the year in flocks, could be influential. Therefore, ocular inoculation of the vaccine is considered as an alternative proved to be safer. 6, 8, 10, 16 In our experiment, all animals were detected as positive using mRBT two weeks after immunization. Stournara et al. 9 also reported a hundred percent positive results in mRBT of non-pregnant ewes 21 days post-vaccination. In another study by Zundel et al., 16 all ewes vaccinated at mid-pregnancy using the same dose as ours were positive in RBT 2 weeks following vaccination.
The proportion of positive vaccinated ewes in iELISA reached its maximum after 4 weeks. A similar result has been observed by Stournara et al. 9 which was attributed to the higher affinity of the conjugate used in the assay to immunoglobulin G (IgG). It has also been reported that more than 70 percent of non-vaccinated ewes were detected as negative by iELISA 14 days after challenge with the virulent strain during pregnancy. 17 Because the ewes used in our study were from a brucellosis-free flock without previous exposure to the pathogen, and according to the explanation provided by Stournara et al., 9 negative iELISA results of these naive ewes two weeks after vaccine inoculation suggest antibody responses may be mainly of IgM class at this time. The percentage of positive animals detected by iELISA and mRBT decreased rapidly from 6 weeks post-vaccination to the end of study. Similar performance of iELISA and mRBT in our study is in agreement with results of the study carried out by Stournara et al. 9 However, in the latter study 72.6% and 84% of animals remained positive in iELISA and mRBT, respectively 91 days after immunization, but in our study only 16 ence may be due to age and physiologic status of animals when vaccinated or breed variation in antibody responses. 7, 18 Evaluation of serological responses during the study period using SAT revealed antibody titers fell from the peak reached at week two toward the end of study. SAT results are compatible with the other two tests and the only ewe, which had antibody titer of diagnostic value 12 week after immunization, was also detected as positive in iELISA and mRBT at this interval. While serum antibody level of this ewe was decreasing from 120 IU/mL six weeks following vaccination to 15 IU/mL at week 10, there was a further surge in its antibody titer (120 IU/mL) two weeks later at 12 th week. For this animal, parturition occurred 66 days post-immunization 4 days prior to blood collection for the 10 th week. This suggests that parturition might have effects on antibody responses to vaccination.
Use of vaccine through conjunctival route during second half of pregnancy was safe in terms of abortion induction, and no vaccine excretion in milk and fetal materials was detected soon after delivery. Rev.1 strain delivered conjunctivally is known to have a spread confined mainly to head lymph nodes. 8 Considering normal delivery of all animals one to two months following vaccine inoculation and as vaccine strain was not isolated immediately after parturition, it seems Rev.1 strain was not generalized to the uterus and mammary gland. Although there is no a completely safe way to use Rev.1 vaccine in pregnant small ruminants, 4 it is known that conjunctival administration of the vaccine during late pregnancy or before breeding can reduce risks of vaccine-induced abortions and vaccine strain excretion in milk and vaginal discharges, 5 which was also proved in Iranian fat-tailed ewes in this study.
In general, the present experiment showed serological responses to ocular vaccination of pregnant Iranian fat-tailed sheep with standard doses of B. melitensis strain Rev.1 disappeared in a considerable proportion of animals within 12 weeks. Moreover, use of vaccine during late pregnancy did not cause vaccinationinduced abortion and Rev.1 strain excretion in milk and vaginal discharges during immediate postpartum period. Nevertheless, further investigations are required to assess vaccine performance in field conditions.
